In addition to our most advanced projects we have several undisclosed projects that we will continue to develop in-house or in partnership.
These projects include distinct patented compound classes targeting the 5-HT2 receptors as well as ideas from academia, with new targets and subsequently a new mode of action, all with suggested anti-inflammatory properties.
